Citalopram in the Treatment of Alcoholism: a Double-blind Placebo-controlled Study

Abstract
The effect of citalopram and placebo in the treatment of alcoholism was studied in a sample of 62 patients with a follow-up period of four months. The results imply that the new 5-HT re-uptake inhibitor citalopram is significantly more effective than placebo in the treatment of alcoholism. The present study indicates that even severe alcoholism may be treated effectively with a generally available psychopharmacological agent.